Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ?

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 785-789

  Fraile, Manel ^a   Gubern, Josep M ^a   Rull, Miquel ^a   Julián, Francisco J ^a   Serra, Cristina ^a   Llatjós, Mariona ^b   Culell, Pere ^b   Puig, Pere ^a   Solà, Montse ^a   Vallejos, Virginia ^a   Mariscal, Antonio ^a   Janer, Joan ^a   Deulofeu, Pere ^a   Fusté, Ferràn ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL DE MATARÓ   (Spain)

Author keywords

Sentinel node biopsy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CARCINOMA IN SITU; CHILD; CLINICAL FEATURE; CORRELATION ANALYSIS; DATA BASE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PATIENT SELECTION; PROSPECTIVE STUDY; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; RISK; SENTINEL LYMPH NODE BIOPSY;

EID: 33748757516     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000230074.39071.bf     Document Type: Article

References (25)

1. Silverstein MJ, Rosser RJ, Gibson ED. Axillary lymph node dissection of intraductal breast carcinoma - is it indicated? Cancer 1987; 59:1819-1824.
2. Pendas S, Dauway E, Giuliano R, Ku NN, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000; 7:15-20.
3. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001; 67:513-521.
4. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003; 186:368-370.
5. Intra M, Veronesi P, Mazzarol G, Galimberti V, Luini A, Sachinni V, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003; 138:309-313.
6. Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg 2003; 186:112-116.
7. Fraile M, Rull M, Julian FJ, Fuste F, Barnadas A, Llatjos M, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 2000; 11:701-705. Erratum in Ann Oncol 2000; 11:1619.
8. Zujewski J, Eng-Wong J. Sentinel lymph node biopsy in the management of ductal carcinoma in situ. Clin Breast Cancer 2005; 6:216-222.
9. Moran CJ, Kell MR, Kerin MJ. The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur J Surg Oncol 2005; 31:1105-1111.
10. Lyman GH, Giuliano AE, Somerfield MR, Benson III AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-7720.
11. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous an unwarranted direction. Ann Surg Oncol 2001; 8:275-277.
12. Sakorafas GH, Farley DR. Optimal management of ductal carcinoma in situ of the breast. Surg Oncol 2003; 12:221-240.
13. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002; 94:2542-2551.
14. Diaz NM, Cox CE, Ebert M, Clark JD, Vrcel V, Stowell N, et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol 2004; 28:1641-1645.
15. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, et al. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000; 7:636-642.
16. Intra M, Zurrida S, Maffini F, Sonzogni A, Trifiro G , Gennari R, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 2003; 10:1160-1165.
17. Veronesi P, Intra M, Vento AR, Naninato P, Caldarella P, Raganelli G, et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 2005; 14:520-522.
18. Farkas EA, Stolier AJ, Teng SC, Bolton JS, Fuhram GM. An argument against routine sentinel node mapping for DCIS. Am Surg 2004; 70:13-17.
19. Mittendorf ME, Arciero CA, Gutchell V, Hooke J, Schriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 2005; 62:253-257.
20. Yen TW, Hunt KK, Ross MI, Mirza NQ, Baviera GV, Meric-Bernstam F, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005; 200:516-526.
21. Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005; 190:563-566.
22. Zavagno G, Carcoforo P, Marconato R, Franchini Z, Scalco G, Burelli P, et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 2005; 5:18.
23. Camp R, Feezor R, Kasraeian A, Cendan J, Schell S, Wilkinson E, et al. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J 2005; 11:394-397.
24. Tamhane R, Dahlstrom JE, McCallum DD, Buckingham JM. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol 2002; 9:999-1003.
25. Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ. A clinicopathologic study with long-term follow-up. Cancer 2003; 98:2105-2113.